Asymchem Laboratories (Tianjin) Co., Ltd. (SHE:002821)
114.41
-3.00 (-2.56%)
Apr 17, 2026, 3:04 PM CST
SHE:002821 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 6,321 | 5,789 | 7,110 | 5,290 | 6,234 |
Short-Term Investments | 213.77 | 254.12 | - | - | - |
Trading Asset Securities | 1,117 | 1,540 | 1,906 | 2,151 | 401.2 |
Cash & Short-Term Investments | 7,651 | 7,583 | 9,016 | 7,441 | 6,636 |
Cash Growth | 0.90% | -15.89% | 21.17% | 12.13% | 212.32% |
Accounts Receivable | 2,061 | 1,939 | 2,092 | 2,515 | 1,817 |
Other Receivables | 155.44 | 204.36 | 170.87 | 17.87 | 4.17 |
Receivables | 2,216 | 2,143 | 2,263 | 2,533 | 1,821 |
Inventory | 1,471 | 1,193 | 945.35 | 1,510 | 1,396 |
Other Current Assets | 168.06 | 130.25 | 128.26 | 376.4 | 457.51 |
Total Current Assets | 11,506 | 11,050 | 12,352 | 11,860 | 10,310 |
Property, Plant & Equipment | 6,596 | 6,138 | 5,358 | 5,370 | 3,700 |
Long-Term Investments | 808.3 | 902.14 | 867.19 | 390.33 | 395.61 |
Goodwill | 146.18 | 146.18 | 146.18 | 146.18 | 146.18 |
Other Intangible Assets | 421.8 | 430.17 | 465.61 | 57.68 | 62.96 |
Long-Term Deferred Tax Assets | 275.62 | 248.35 | 213.21 | 177.86 | 186.93 |
Long-Term Deferred Charges | 118.43 | 99.1 | 122.39 | - | - |
Other Long-Term Assets | 404.69 | 274.62 | 242.4 | 237.12 | 354.71 |
Total Assets | 20,277 | 19,289 | 19,767 | 18,239 | 15,156 |
Accounts Payable | 589.04 | 450.85 | 453.62 | 569.99 | 551.87 |
Accrued Expenses | 428.3 | 381.57 | 339.85 | 398.73 | 213.49 |
Short-Term Debt | - | - | 12.23 | - | 375.39 |
Current Portion of Leases | 52.71 | 42.23 | 28.53 | 28.49 | 13.22 |
Current Income Taxes Payable | 69.47 | 50.18 | 31.24 | 67.42 | 63.19 |
Current Unearned Revenue | 251.47 | 269.94 | 221.2 | 277.33 | 131.05 |
Other Current Liabilities | 577.49 | 514.59 | 714.13 | 835.14 | 856.6 |
Total Current Liabilities | 1,968 | 1,709 | 1,801 | 2,177 | 2,205 |
Long-Term Leases | 256.47 | 282.53 | 106.49 | 109.86 | 45.88 |
Long-Term Unearned Revenue | 294.73 | 298.62 | 232.6 | 168.12 | 179.05 |
Long-Term Deferred Tax Liabilities | 111.6 | 134.7 | 117.29 | 89.2 | 116.55 |
Other Long-Term Liabilities | 0.03 | 0.79 | - | - | - |
Total Liabilities | 2,631 | 2,426 | 2,257 | 2,544 | 2,546 |
Common Stock | 360.56 | 367.72 | 369.47 | 369.92 | 263.04 |
Additional Paid-In Capital | 9,067 | 9,396 | 9,612 | - | - |
Retained Earnings | 9,025 | 8,287 | 7,969 | 6,364 | 3,274 |
Treasury Stock | -838.45 | -1,233 | -494.01 | -1,247 | - |
Comprehensive Income & Other | 21.54 | 27.18 | 22.88 | 10,160 | 9,073 |
Total Common Equity | 17,635 | 16,845 | 17,480 | 15,647 | 12,610 |
Minority Interest | 11.04 | 17.19 | 30.26 | 47.58 | - |
Shareholders' Equity | 17,646 | 16,863 | 17,510 | 15,695 | 12,610 |
Total Liabilities & Equity | 20,277 | 19,289 | 19,767 | 18,239 | 15,156 |
Total Debt | 309.18 | 324.75 | 147.25 | 138.35 | 434.49 |
Net Cash (Debt) | 7,342 | 7,259 | 8,869 | 7,302 | 6,201 |
Net Cash Growth | 1.15% | -18.15% | 21.45% | 17.76% | 197.31% |
Net Cash Per Share | 20.49 | 20.58 | 24.47 | 19.91 | 18.17 |
Filing Date Shares Outstanding | 359.72 | 350.89 | 362.78 | 369.37 | 368.31 |
Total Common Shares Outstanding | 359.72 | 350.89 | 362.78 | 369.37 | 368.31 |
Working Capital | 9,538 | 9,341 | 10,551 | 9,683 | 8,106 |
Book Value Per Share | 49.02 | 48.01 | 48.18 | 42.36 | 34.24 |
Tangible Book Value | 17,067 | 16,269 | 16,868 | 15,444 | 12,401 |
Tangible Book Value Per Share | 47.45 | 46.36 | 46.50 | 41.81 | 33.67 |
Buildings | 2,676 | 2,464 | 2,060 | 1,583 | 1,148 |
Machinery | 4,099 | 3,380 | 3,318 | 3,165 | 1,959 |
Construction In Progress | 1,827 | 1,867 | 1,331 | 1,072 | 1,047 |
Leasehold Improvements | - | - | - | 155.31 | 48.18 |
Order Backlog | 1,385 | - | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.